|
Re: Presentation
|
|
Resverlogix Corp.
|
Oct 05, 2021 07:20PM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 11:29AM
|
|
Re: Pre-market matching bids!! $1.81 !!!
|
4
|
Resverlogix Corp.
|
Jan 11, 2018 09:17AM
|
|
Re: POTENTIAL.
|
5
|
Resverlogix Corp.
|
Nov 12, 2015 06:30PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
3
|
Resverlogix Corp.
|
Nov 14, 2022 06:20PM
|
|
Re: Potential funding for BETONMACE2 and Covid trial
|
5
|
Resverlogix Corp.
|
Oct 25, 2021 07:30PM
|
|
Re: Potential
|
3
|
Zenith Epigenetics
|
Jul 21, 2021 10:41AM
|
|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 19, 2017 03:56PM
|
|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 19, 2017 04:21PM
|
|
Re: Positives & negatives
|
5
|
Resverlogix Corp.
|
Sep 17, 2015 10:43AM
|
|
Re: Positives & negatives
|
4
|
Resverlogix Corp.
|
Sep 16, 2015 12:57PM
|
|
Re: Positives & negatives
|
3
|
Resverlogix Corp.
|
Sep 16, 2015 03:35PM
|
|
Re: Pointing in the right direction & bogus Lilly
|
5
|
Resverlogix Corp.
|
Jun 21, 2018 10:32AM
|
|
Re: Placebo or Standard of Care
|
1
|
Resverlogix Corp.
|
Nov 02, 2019 05:47PM
|
|
Re: Placebo or Standard of Care
|
|
Resverlogix Corp.
|
Nov 02, 2019 06:03PM
|
|
Re: Phase III approval rates....
|
4
|
Resverlogix Corp.
|
Jul 12, 2015 03:08PM
|
|
Re: Phase 3 Status with a European Regulatory Authority
|
3
|
Resverlogix Corp.
|
Jun 22, 2015 08:45AM
|
|
Re: Phase 3 - Fall Start
|
1
|
Resverlogix Corp.
|
Jun 22, 2015 11:56AM
|
|
Re: Pharmacological Modulation of BET Family in Sepsis
|
3
|
Resverlogix Corp.
|
Mar 11, 2021 11:36AM
|
|
Re: PFE "is only the start of the spending spree that the company has planned"maybe,just maybe
|
7
|
Resverlogix Corp.
|
May 11, 2022 02:19PM
|
